TY - JOUR
T1 - Key interactions by conserved polar amino acids located at the transmembrane helical boundaries in Class B GPCRs modulate activation, effector specificity and biased signalling in the glucagon-like peptide-1 receptor
AU - Wootten, Denise
AU - Reynolds, Christopher A.
AU - Smith, Kevin J.
AU - Mobarec, Juan C.
AU - Furness, Sebastian G.B.
AU - Miller, Laurence J.
AU - Christopoulos, Arthur
AU - Sexton, Patrick M.
N1 - Funding Information:
This work was supported by National Health and Medical Research Council of Australia (NHMRC) project grants [ 1061044 ] and [ 1065410 ], and NHMRC program grant [ 1055134 ]; Biotechnology and Biological Sciences Research Council of the United Kingdom project grant [ BB/M006883/1 ]; and Medical Research Council (UK) grant [ G1001812 ].
Publisher Copyright:
© 2016 The Authors
PY - 2016/10/15
Y1 - 2016/10/15
N2 - Class B GPCRs can activate multiple signalling effectors with the potential to exhibit biased agonism in response to ligand stimulation. Previously, we highlighted key TM domain polar amino acids that were crucial for the function of the GLP-1 receptor, a key therapeutic target for diabetes and obesity. Using a combination of mutagenesis, pharmacological characterisation, mathematical and computational molecular modelling, this study identifies additional highly conserved polar residues located towards the TM helical boundaries of Class B GPCRs that are important for GLP-1 receptor stability and/or controlling signalling specificity and biased agonism. This includes (i) three positively charged residues (R3.30227, K4.64288, R5.40310) located at the extracellular boundaries of TMs 3, 4 and 5 that are predicted in molecular models to stabilise extracellular loop 2, a crucial domain for ligand affinity and receptor activation; (ii) a predicted hydrogen bond network between residues located in TMs 2 (R2.46176), 6 (R6.37348) and 7 (N7.61406 and E7.63408) at the cytoplasmic face of the receptor that is important for stabilising the inactive receptor and directing signalling specificity, (iii) residues at the bottom of TM 5 (R5.56326) and TM6 (K6.35346 and K6.40351) that are crucial for receptor activation and downstream signalling; (iv) residues predicted to be involved in stabilisation of TM4 (N2.52182 and Y3.52250) that also influence cell signalling. Collectively, this work expands our understanding of peptide-mediated signalling by the GLP-1 receptor.
AB - Class B GPCRs can activate multiple signalling effectors with the potential to exhibit biased agonism in response to ligand stimulation. Previously, we highlighted key TM domain polar amino acids that were crucial for the function of the GLP-1 receptor, a key therapeutic target for diabetes and obesity. Using a combination of mutagenesis, pharmacological characterisation, mathematical and computational molecular modelling, this study identifies additional highly conserved polar residues located towards the TM helical boundaries of Class B GPCRs that are important for GLP-1 receptor stability and/or controlling signalling specificity and biased agonism. This includes (i) three positively charged residues (R3.30227, K4.64288, R5.40310) located at the extracellular boundaries of TMs 3, 4 and 5 that are predicted in molecular models to stabilise extracellular loop 2, a crucial domain for ligand affinity and receptor activation; (ii) a predicted hydrogen bond network between residues located in TMs 2 (R2.46176), 6 (R6.37348) and 7 (N7.61406 and E7.63408) at the cytoplasmic face of the receptor that is important for stabilising the inactive receptor and directing signalling specificity, (iii) residues at the bottom of TM 5 (R5.56326) and TM6 (K6.35346 and K6.40351) that are crucial for receptor activation and downstream signalling; (iv) residues predicted to be involved in stabilisation of TM4 (N2.52182 and Y3.52250) that also influence cell signalling. Collectively, this work expands our understanding of peptide-mediated signalling by the GLP-1 receptor.
KW - Biased agonism
KW - Cell signaling
KW - G protein-coupled receptor
KW - Glucagon-like peptide-1 receptor
UR - http://www.scopus.com/inward/record.url?scp=84989879867&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84989879867&partnerID=8YFLogxK
U2 - 10.1016/j.bcp.2016.08.015
DO - 10.1016/j.bcp.2016.08.015
M3 - Article
C2 - 27569426
AN - SCOPUS:84989879867
SN - 0006-2952
VL - 118
SP - 68
EP - 87
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
ER -